BiondVax’s Financial Reports and Results

Please select from the links below to the financial reports with BiondVax’s quarterly and year-end financial results.


Results Period

Press Release

Report

XBRL

Q1 2023

Press Release

SEC

FY 2022

Press Release

SEC

HTML

Q3 2022

Press Release

SEC

 

Q2 2022

Press Release

SEC

 

Q1 2022

Press Release

SEC

 

FY & Q4 2021

Press Release

SEC

ZIP

Q3 2021

Press Release

SEC

 

Q2 2021

Press Release

SEC

 

Q1 2021

Press Release

SEC

 

FY & Q4 2020

Press Release

SEC

ZIP

Q3 2020

Press Release

SEC

 

Q2 2020

Press Release

SEC

 

Q1 2020

Press Release

SEC

 

FY & Q4 2019

Press Release

SEC

ZIP

Q3 2019

Press Release

SEC

 

Q2 2019

Press Release

SEC

 

Q1 2019

Press Release

SEC

 

FY & Q4 2018

Press Release

SEC

ZIP

Q3 2018

Press Release

SEC

 

Q2 2018

Press Release

SEC

 

Q1 2018

Press Release

SEC

 

FY & Q4 2017

Press Release

PDF

ZIP

Q3 2017

Press Release

SEC

 

Q2 2017

Press Release

SEC

 

Q1 2017

Press Release

SEC

 

FY & Q4 2016

Press Release

PDF

 

Q3 2016

Press Release

PDF

 

Q2 2016

Press Release

PDF

 

Q1 2016

Press Release

PDF

 

FY & Q4 2015

Press Release

PDF

 

BiondVax routinely files periodic reports with the SEC. Note that BiondVax files with the SEC as a foreign filer. Click here to view SEC Filings.

Note: The above includes hyperlinks to a third-party SEC Filings web site. BiondVax does not maintain or provide information directly to this site. BiondVax makes no representations or warranties with respect to the information contained in this site.